Terje Espevik Selected Research

Inflammation (Inflammations)

1/2024	SLAMF1-derived peptide exhibits cardio protection after permanent left anterior descending artery ligation in mice.
12/2023	Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo.
1/2023	Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model.
1/2022	Thrombin Differentially Modulates the Acute Inflammatory Response to Escherichia coli and Staphylococcus aureus in Human Whole Blood.
1/2021	Combined blockade of complement C5 and TLR co-receptor CD14 synergistically inhibits pig-to-human corneal xenograft induced innate inflammatory responses.
10/2020	Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
1/2019	Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis.
1/2019	Serum Omega-6 Fatty Acids and Immunology-Related Gene Expression in Peripheral Blood Mononuclear Cells: A Cross-Sectional Analysis in Healthy Children.
1/2018	IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
1/2018	Combined Inhibition of C5 and CD14 Attenuates Systemic Inflammation in a Piglet Model of Meconium Aspiration Syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terje Espevik Research Topics

Disease

35	Inflammation (Inflammations) 01/2024 - 07/2003
15	Atherosclerosis 12/2021 - 10/2006
14	Sepsis (Septicemia) 01/2023 - 01/2008
9	Atherosclerotic Plaque (Atheroma) 01/2019 - 03/2014
6	Infections 01/2020 - 01/2008
5	Carotid Artery Diseases 10/2020 - 01/2017
5	Myocardial Infarction 08/2016 - 10/2006
4	Wounds and Injuries (Trauma) 10/2012 - 07/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2020
3	Non-ST Elevated Myocardial Infarction 11/2018 - 08/2016
3	Carotid Stenosis (Carotid Artery Stenosis) 07/2017 - 01/2017
3	Heart Failure 10/2014 - 10/2006
3	Reperfusion Injury 11/2013 - 11/2012
3	Neoplasms (Cancer) 07/2012 - 01/2004
2	Infarction (Infarctions) 01/2024 - 07/2013
2	Pneumonia (Pneumonitis) 01/2023 - 01/2019
2	Necrosis 10/2020 - 04/2001
2	Thrombosis (Thrombus) 01/2019 - 07/2017
2	Thromboinflammation 01/2019 - 01/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2014 - 02/2013
2	HIV Infections (HIV Infection) 12/2004 - 07/2004
1	Shock 12/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Peritonitis 01/2023
1	Neonatal Sepsis 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2022
1	Acute Coronary Syndrome 10/2020
1	Stable Angina 10/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Hemolysis 01/2019
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Ischemic Stroke 07/2017
1	Pathologic Constriction (Stenosis) 01/2017

Drug/Important Bio-Agent (IBA)

27	Complement System Proteins (Complement)IBA 01/2021 - 01/2008
19	CytokinesIBA 12/2023 - 04/2001
15	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 07/2003
12	CholesterolIBA 12/2021 - 04/2010
9	InflammasomesIBA 10/2020 - 04/2010
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2011
5	Peptides (Polypeptides)IBA 01/2024 - 07/2003
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2003
4	Complement C5 (Complement 5)IBA 01/2023 - 06/2014
4	Interleukin-8 (Interleukin 8)IBA 01/2023 - 08/2010
3	Pattern Recognition ReceptorsIBA 12/2023 - 07/2004
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 07/2003
3	CyclodextrinsIBA 01/2019 - 04/2016
3	tocilizumab (atlizumab)FDA Link 11/2018 - 08/2016
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2018 - 08/2016
3	Messenger RNA (mRNA)IBA 07/2017 - 06/2014
3	Complement Inactivating AgentsIBA 01/2017 - 11/2013
3	EnzymesIBA 01/2017 - 05/2009
3	Toll-Like Receptor 3IBA 06/2014 - 01/2012
3	AlginatesIBA 10/2012 - 04/2001
3	Toll-Like Receptor 2IBA 10/2006 - 07/2004
2	InterleukinsIBA 10/2020 - 04/2010
2	asparaginylendopeptidase (legumain)IBA 01/2020 - 01/2017
2	Cysteine Proteases (Cysteine Protease)IBA 01/2020 - 01/2017
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 07/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2015
2	Interleukin-18 (Interleukin 18)IBA 01/2016 - 04/2010
2	Toll-Like Receptor 4IBA 01/2016 - 02/2011
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2016 - 10/2006
2	ChemokinesIBA 05/2011 - 01/2009
2	Lipocalin-2IBA 08/2010 - 05/2009
2	LigandsIBA 05/2009 - 01/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 07/2003
1	acetyl- phenylalanyl- threonyl- leucyl- aspartyl- alanyl- aspartyl- phenylalanineIBA 12/2023
1	Caspase 8 (Caspase-8)IBA 01/2023
1	benzyloxycarbonyl- isoleucyl- glutamyl- threonyl- aspartic acid fluoromethyl ketoneIBA 01/2023
1	Cardiotonic Agents (Cardiac Stimulants)IBA 08/2022
1	PeptidomimeticsIBA 08/2022
1	glycyl-prolyl-arginyl-prolineIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	lepirudin (Refludan)FDA Link 01/2022
1	Thrombin FDA Link 01/2022
1	FibrinIBA 01/2022
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 10/2020
1	Factor VaIBA 10/2020
1	HemopexinIBA 01/2019
1	alpha-cyclodextrinIBA 01/2019
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2019
1	HaptoglobinsIBA 01/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019
1	LipidsIBA 01/2019
1	Prothrombin (Factor II)IBA 01/2019
1	Complement C3b (C3bi)IBA 01/2019
1	Heme (Haem)IBA 01/2019
1	AnaphylatoxinsIBA 01/2018
1	Anaphylatoxin C5a ReceptorIBA 01/2018
1	ImmunosorbentsIBA 01/2017
1	Interleukin-27 (Interleukin 27)IBA 01/2017
1	Troponin T (Troponin T1)IBA 08/2016
1	Trinitrotoluene (TNT)IBA 08/2016

Therapy/Procedure

8	Therapeutics 01/2023 - 01/2004
2	Intravenous Infusions 11/2018 - 01/2017
2	Ligation 06/2014 - 07/2013
1	Percutaneous Coronary Intervention 01/2020
1	Carotid Endarterectomy 07/2017